A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/22/1998	WO1998046221A1 Method for treating fungal infections
10/22/1998	WO1998046218A1 Phorbol esters as anti-neoplastic agents
10/22/1998	WO1998046217A1 Molecular complex and control-release of alpha hydroxyacids
10/22/1998	WO1998046216A1 Remedies for frequent urination and urinary incontinence
10/22/1998	WO1998046214A1 Pharmaceutical tablet of amiodarone salt
10/22/1998	WO1998046213A1 Cefadroxil monohydrate tablet formulation
10/22/1998	WO1998046207A1 Compositions containing an antifungal and a cationic agent
10/22/1998	WO1998046206A1 Skin cream composition
10/22/1998	WO1998046193A2 Synergistic method for treating a neoplasm
10/22/1998	WO1998046166A1 Lipid soluble thiamine for prevention and treatment of age-related cognitive impairment
10/22/1998	WO1998046080A1 Nucleophile substituted ecteinascidins and n-oxide ecteinascidins
10/22/1998	WO1998046077A1 A method for treating papillomavirus infections
10/22/1998	WO1998046076A1 Retinoid related molecules for the inhibition of endothelin-1 overproduction in disease
10/22/1998	WO1998036732A3 Combination preparation for orally administered antibiotics
10/22/1998	WO1998036730A3 Compositions for treating acne rosacea
10/22/1998	WO1998032463A3 Lyophilizate of lipid complex of water insoluble porphyrins
10/22/1998	WO1998030685A3 Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation
10/22/1998	WO1998029407A3 N-(pyridinylamino)isoindolines for treating alzheimer's and depression
10/22/1998	WO1998002190A3 Cationic amphiphile/dna complexes
10/22/1998	DE19716713A1 Arzneimittel, enthaltend Ibuprofenthioester als Hemmer der Nf-kappaB abhängigen Bildung von Mediatoren von Entzündung und Schmerz A drug containing Ibuprofenthioester dependent as inhibitors of Nf-kappaB formation of mediators of inflammation and pain
10/22/1998	DE19716257A1 Fungizide Wirkstoffkombination Fungicidal drug combination
10/22/1998	DE19716120A1 Verwendung von cholesterinsenkenden Mitteln Use of cholesterol-lowering drugs
10/22/1998	DE19715594A1 Analgetika-Kombination Analgesic combination
10/22/1998	CA2706609A1 Osteoprotegerin binding proteins and receptors
10/22/1998	CA2634700A1 Drug delivery via therapeutic hydrogels
10/22/1998	CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/22/1998	CA2465698A1 Extended release formulations of erythromycin derivatives
10/22/1998	CA2293309A1 Method for treating fungal infections
10/22/1998	CA2293306A1 Synergistic method for treating a neoplasm
10/22/1998	CA2289476A1 Modified tnf.alpha. molecules, dna encoding such modified tnf.alpha. molecules and vaccines comprising such modified tnf.alpha. molecules and dna
10/22/1998	CA2288171A1 Pyridazine and phthalazine derivatives, process of their preparation and their use as anticonvulsants
10/22/1998	CA2287518A1 A novel th2-specific gene
10/22/1998	CA2287465A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
10/22/1998	CA2287085A1 Tumor necrosis factor receptor related proteins tango-63d and tango-63e
10/22/1998	CA2286909A1 5,7-disubstituted 4-aminopyrido¬2,3-d\|pyrimidine compounds and their use as adenosine kinase inhibitors
10/22/1998	CA2286904A1 Pharmaceutical tablet of amiodarone salt
10/22/1998	CA2286789A1 Compounds
10/22/1998	CA2286766A1 Alkaloid halide salts of swainsonine and methods of use
10/22/1998	CA2286738A1 Crambescidin compounds
10/22/1998	CA2286730A1 Molecular complex and control-release of alpha hydroxyacids
10/22/1998	CA2286666A1 Lipid soluble thiamine for prevention and treatment of age-related cognitive impairment
10/22/1998	CA2286620A1 A new process
10/22/1998	CA2286592A1 5,6,7-trisubstituted-4-aminopyridol[2,3-d]pyrimidine compounds
10/22/1998	CA2286557A1 Phorbol esters as anti-neoplastic agents
10/22/1998	CA2286263A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998	CA2286261A1 Retinoid antagonists for prevention of surgical adhesions
10/22/1998	CA2286181A1 Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity: compounds, compositions and methods
10/22/1998	CA2286079A1 Cefadroxil monohydrate tablet formulation
10/22/1998	CA2286078A1 Novel compounds
10/22/1998	CA2285968A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998	CA2285950A1 Method of treating chronic progressive vascular scarring diseases
10/22/1998	CA2285610A1 5-(2-imidazolinylamino)benzimidazole compounds useful as alpha-2 adrenoceptor agonists
10/22/1998	CA2285603A1 Substituted heteroaromatic 5-ht1f agonists
10/22/1998	CA2285601A1 Protease inhibitors
10/22/1998	CA2285572A1 A method for treating papillomavirus infections
10/22/1998	CA2285335A1 Selective factor xa inhibitors
10/22/1998	CA2284988A1 Medicinal composition
10/22/1998	CA2284726A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998	CA2284525A1 Inhibitors of cholesterol esterase
10/22/1998	CA2282390A1 Thermogenic composition and benzazepine thermogenics
10/22/1998	CA2234399A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/22/1998	CA2231740A1 Cdna clone hmtmf81 that encodes a novel human 7-transmembrane receptor
10/21/1998	EP0872556A2 Process for the preparation of moenomycin A
10/21/1998	EP0872553A1 Chimeric and/or growth-restricted flaviviruses
10/21/1998	EP0872550A2 cDNA clone HACCH94 that encodes a human 7-transmembrane receptor
10/21/1998	EP0872478A2 Intermediates for the preparation of 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
10/21/1998	EP0872465A2 Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl) butane and intermediates thereof
10/21/1998	EP0872248A2 Pharmaceutical vehicles for reducing transdermal flux
10/21/1998	EP0872247A1 Pharmaceutical formulation
10/21/1998	EP0872246A1 Novel drug for relieving pain and promoting the removal of calculi in urolithiasis
10/21/1998	EP0872239A2 Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia
10/21/1998	EP0872238A2 Use of olanzapine for the manufacture of a medicament for neuroprotection
10/21/1998	EP0872237A1 Method and compositions for the synthesis of BCH-189 and related compounds
10/21/1998	EP0872236A1 Eye drops
10/21/1998	EP0872235A1 Therapeutic agents
10/21/1998	EP0872232A1 Pharmaceutical preparation with delayed release of active ingredient
10/21/1998	EP0872230A1 Compositions containing an antifungal and a cationic agent
10/21/1998	EP0871757A1 Conditionally replicating viral vectors and their use
10/21/1998	EP0871748A2 Delivery of biologically active polypeptides
10/21/1998	EP0871738A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications
10/21/1998	EP0871735A1 Therapeutic and diagnostic compositions
10/21/1998	EP0871733A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
10/21/1998	EP0871732A1 Method of treating sepsis
10/21/1998	EP0871730A1 Combination pdgf, kgf, igf and igfbp for wound healing
10/21/1998	EP0871721A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
10/21/1998	EP0871713A2 The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis
10/21/1998	EP0871710A1 Recombinant c-proteinase and processes, methods and uses thereof
10/21/1998	EP0871703A1 Dna encoding glutamate gated chloride channels
10/21/1998	EP0871672A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
10/21/1998	EP0871670A2 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR
10/21/1998	EP0871666A1 Receptor-selective somatostatin analogs
10/21/1998	EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998	EP0871657A1 Methods for treatment and prevention of diabetes
10/21/1998	EP0871653A1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds
10/21/1998	EP0871647A1 Oligomers which inhibit expression of collagen genes
10/21/1998	EP0871639A1 Novel orthosomycins from micromonospora carbonacea
10/21/1998	EP0871638A1 Novel aminooligosaccharide derivative and process for preparing the same
10/21/1998	EP0871635A1 Isomerisation process
10/21/1998	EP0871632A1 Production of a crystalline salt of amoxicillin
10/21/1998	EP0871631A1 Antiparasitic marcfortines and paraherquamides

1 ... 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 6610 6611 ... 7860